Abstract
The application of optical imaging technologies for drug discovery research and the development of novel preclinical animal models has expanded with tremendous vigor in the past few years. The fact that fluorescent dyes can be detected at low concentrations and nonionizing and harmless radiation is applied with rather low technical effort makes optical techniques attractive for routine use in the animal imaging laboratory. Novel imaging probes and contrast agents have been designed in a broad variety addressing the various requirements given by the disease problem at the preclinical animal imaging stage. Moreover, the industry has identified this field as a market from the side both the imaging equipment and the fluorescent probes applied as readily injectable contrast agents or reactive labels for bioconjugation chemistry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Achilefu S (2004) Lighting up tumors with receptor-specific optical molecular probes. Technol Cancer Res Treat 3:393–409
Azar S, Intes X (2008) Translational multimodality optical imaging. Artech House, Boston
Barnett EM, Zhang X, Maxwell D, Chang Q, Piwnica-Worms D (2009) Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci USA 106:9391–9396
Becker A, Hessenius C, Licha K, Ebert B, Sukowski U, Semmler W, Wiedenmann B, Grötzinger C (2001) Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 19:327–331
Bentolila LA, Ebenstein Y, Weiss S (2009) Quantum dots for in vivo small-animal imaging. J Nucl Med 50:493–496
Bremer C, Tung CH, Weissleder R (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 7:743–748
Fischer T, Gemeinhardt I, Wagner S, Stieglitz DV, Schnorr J, Hermann KG, Ebert B, Petzelt D, Macdonald R, Licha K, Schirner M, Krenn V, Kamradt T, Taupitz M (2006) Assessment of unspecific near-infrared dyes in laser-induced fluorescence imaging of experimental arthritis. Acad Radiol 13:4–13
Foster AE, Kwon S, Ke S, Lu A, Eldin K, Sevick-Muraca E, Rooney CM (2008) In vivo fluorescent optical imaging of cytotoxic T lymphocyte migration using IRDye800CW near-infrared dye. Appl Opt 47:5944–5952
Hermanson GT (1996) Bioconjugate techniques. Academic, San Diego
Klohs J, Steinbrink J, Bourayou R, Mueller S, Cordell R, Licha K, Schirner M, Dirnagl U, Lindauer U, Wunder A (2009) Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood-brain barrier impairment after focal cerebral ischemia in mice. J Neurosci Methods 180(1):126–32
Lee SB, Hassan M, Fisher R, Chertov O, Chernomordik V, Kramer-Marek G, Gandjbakhche A, Capala J (2008) Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res 14:3840–3849
Licha K, Schirner M, Henry G (2008) Optical agents. In: Schwaiger M (ed) Handbook of experimental pharmacology, vol 185, part 2. Springer, Heidelberg, pp 203–222
Licha K, Olbrich C (2005) Optical imaging in drug discovery and diagnostic applications. Adv Drug Delivery Rev 57:1087–1108
Mier W, Beijer B, Graham K, Hull WE (2002) Fluorescent somatostatin receptor probes for the intraoperative detection of tumor tissue with long-wavelength visible light. Bioorg Med Chem 10:2543–2552
Moon WK, Lin Y, O’Loughlin T, Tang Y, Kim DE, Weissleder R, Tung CH (2003) Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjug Chem 14:539–545
Pauli J, Vag T, Haag R, Spieles M, Wenzel M, Kaiser WA, Resch-Genger U, Hilger I (2009) An in vitro characterization study of new near infrared dyes for molecular imaging. Eur J Med Chem 44:3496–3503
Quadir QA, Radowski MR, Kratz F, Licha K, Hauff P, Haag R (2008) Dendritic multishell architectures for drug and dye transport. J Control Release 132:289–294
Rasmussen JC, Tan IC, Marshall MV, Fife CE, Sevick-Muraca EM (2009) Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol 20:74–82
Resch-Genger U, Grabolle M, Cavaliere-Jaricot S, Nitschke R, Nann T (2008) Quantum dots versus organic dyes as fluorescent labels. Nat Methods 9:763–775
Richards G, Soubrane G, Yanuzzi L (1998) Fluorescein and ICG angiography. Thieme, Germany
Stefflova K, Chen J, Zheng G (2007) Using molecular beacons for cancer imaging and treatment. Front Biosci 12:4709–4721
Tung CH (2004) Fluorescent peptide probes for in vivo diagnostic imaging. Biopolymers 76:391–403
Ulrich G, Ziessel R, Harriman A (2008) The chemistry of fluorescent bodipy dyes: versatility unsurpassed. Angew Chem Int Ed 47:1184–1201
Wall A, Persigehl T, Hauff P, Licha K, Schirner M, Müller S, von Wallbrunn A, Matuszewski L, Heindel W, Bremer C (2008) Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG). Breast Cancer Res 10:R23
Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17:375–378
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Licha, K. (2011). Optical Probes. In: Kiessling, F., Pichler, B. (eds) Small Animal Imaging. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12945-2_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-12945-2_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12944-5
Online ISBN: 978-3-642-12945-2
eBook Packages: MedicineMedicine (R0)